ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

Barchart · 11/26 00:30

Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company’s top investor

Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer Interface (BCI) as part of the Company’s investigational ARC-BCI System

Read more at globenewswire.com